Prelude Therapeutics
PRLD
#9260
Rank
NZ$91.11 M
Marketcap
$1.66
Share price
0.57%
Change (1 day)
-68.97%
Change (1 year)

EPS for Prelude Therapeutics (PRLD)

EPS in 2023 (TTM): -$3.51

According to Prelude Therapeutics's latest financial reports the company's current EPS (TTM) is -$3.71. In 2022 the company made an earnings per share (EPS) of -$4.18 a decrease over its 2021 EPS that were of -$4.14.

EPS history for Prelude Therapeutics from 2020 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$3.51-15.94%
2022-$4.180.83%
2021-$4.14-61.3%
2020-$10.70

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$3.73 0.46%๐Ÿ‡บ๐Ÿ‡ธ USA